education
Download App
Indonesia
search
Masuk
Home
Find Drugs
Pill Identifier
Find Drug Company
Diseases
Medical News & Updates
Country
Hong Kong
India
Indonesia
Malaysia
Philippines
Singapore
Thailand
Vietnam
Australia
Korea
New Zealand
search
UserName
Profession
Email
Account
Manage Account
Change Password
Sign Out
Home
Find Drugs
Pill Identifier
Find Drug Company
Diseases
Medical News & Updates
Other Services
Education
Download App
Country
Indonesia
Hong Kong
India
Indonesia
Malaysia
Philippines
Singapore
Thailand
Vietnam
Australia
Korea
New Zealand
Account
Masuk
Home
Find Drugs
Pill Identifier
Find Drug Company
Diseases
Medical News & Updates
Iklan
Iklan
MIMS home
Drugs
Info
Ostenil/Ostenil Plus
Ostenil/Ostenil Plus
sodium hyaluronate
Manufacturer:
Meprofarm
Marketer:
Meprofarm
SELECT
Concise Prescribing Info
Bahasa Concise Prescribing Info
Concise Prescribing Info
Bahasa Concise Prescribing Info
Concise Prescribing Info
Contents
Na hyaluronate (Ostenil Plus: mannitol)
Indications/Uses
Pain & restricted mobility in degenerative & traumatic changes of the knee joint & other synovial joints.
Dosage/Direction for Use
Ostenil
Inj once wkly for a total of 3-5 inj.
Ostenil Plus
Inj once wkly for a total of 1-3 inj.
Contraindications
Hypersensitivity.
Special Precautions
Not recommended for RA or Bechterew disease. Pregnancy & lactation. Childn.
Adverse Reactions
Pain, feeling of heat, redness & swelling/joint effusion.
View
ADR Reporting Link
MIMS Class
Other Drugs Acting on Musculo-Skeletal System
ATC Classification
M09AX01 - hyaluronic acid ; Belongs to the class of other drugs for disorders of the musculo-skeletal system.
S01KA51 - hyaluronic acid, combinations ; Belongs to the class of viscoelastic substances used as ophthalmologic surgical aids.
Regulatory Classification
K
Presentation/Packing
Form
Ostenil inj 20 mg/2 mL
Packing/Price
1's (Rp500,000/boks)
Form
Ostenil Plus inj 40 mg/2 mL
Packing/Price
1's (Rp1,750,000/boks)
Iklan
Iklan
Iklan
Iklan
Iklan
Iklan
Iklan
Daftar Gratis untuk Melanjutkan Membaca
Lanjutkan dengan Google
Daftar dengan Email
Sudah menjadi anggota?
Masuk
Daftar Gratis untuk Melanjutkan Membaca
Lanjutkan dengan Google
Daftar dengan Email
Sudah menjadi anggota?
Masuk